Kate Ward's presentation from Osteoporosis 2016: Relationships between muscle function and bone microarchitecture in the Hertfordshire cohort study.
Find out more at: https://nos.org.uk/conference
Definition of Osteoporosis - Prevalence - Risk factors for Osteoporosis - Diagnosis of Osteoporosis - Clinical manifestations- Laboratory investigations - DEXA - T and Z score - Management of Osteoporosis - Prevention
Osteoporosis is a Skeletal disorder characterized by compromised Bone strength. Bone strength primarily reflects the integration of: 1- Bone Density (Mass) 2- Bone Quality 3- Bone Turnover (Recycling). leading to an increased Fragility and risk of fracture.
Osteoporosis is a serious public health concern due to its prevalence worldwide. Currently over 200 million people worldwide suffer from this disease. Approximately 30% of all postmenopausal women have osteoporosis in the USA & Europe. At least 40% of these women and 15-30% of men will sustain one or more fragility fractures in their remaining lifetime. Ageing of populations worldwide will be responsible for a major increase in the incidence of osteoporosis in postmenopausal women. An initial fracture is a major risk factor for a new fracture. An increased risk of 86% for any fracture in people that have already sustained a fracture. Patients with a history of vertebral fracture have a 2.3-fold increased risk of future hip fracture and a 1.4-fold increase in risk of distal forearm fracture.
Prevention and Treatment of Osteoporosis and Fragility fracture:
A- Therapeutic Life style: 1- Good Nutritious Diet. 2- Exercise. 3- Prevention of falls
B- Drug therapy: 1- Anti resorptive agent. 2- Bone forming agents. 3- Other agents
Kate Ward's presentation from Osteoporosis 2016: Relationships between muscle function and bone microarchitecture in the Hertfordshire cohort study.
Find out more at: https://nos.org.uk/conference
Definition of Osteoporosis - Prevalence - Risk factors for Osteoporosis - Diagnosis of Osteoporosis - Clinical manifestations- Laboratory investigations - DEXA - T and Z score - Management of Osteoporosis - Prevention
Osteoporosis is a Skeletal disorder characterized by compromised Bone strength. Bone strength primarily reflects the integration of: 1- Bone Density (Mass) 2- Bone Quality 3- Bone Turnover (Recycling). leading to an increased Fragility and risk of fracture.
Osteoporosis is a serious public health concern due to its prevalence worldwide. Currently over 200 million people worldwide suffer from this disease. Approximately 30% of all postmenopausal women have osteoporosis in the USA & Europe. At least 40% of these women and 15-30% of men will sustain one or more fragility fractures in their remaining lifetime. Ageing of populations worldwide will be responsible for a major increase in the incidence of osteoporosis in postmenopausal women. An initial fracture is a major risk factor for a new fracture. An increased risk of 86% for any fracture in people that have already sustained a fracture. Patients with a history of vertebral fracture have a 2.3-fold increased risk of future hip fracture and a 1.4-fold increase in risk of distal forearm fracture.
Prevention and Treatment of Osteoporosis and Fragility fracture:
A- Therapeutic Life style: 1- Good Nutritious Diet. 2- Exercise. 3- Prevention of falls
B- Drug therapy: 1- Anti resorptive agent. 2- Bone forming agents. 3- Other agents
Prof. Jon Tobias's presentation from Osteoporosis 2016: What are the properties of the perfect therapy?
Find out more at: https://nos.org.uk/conference
Prof. Jon Tobias's presentation from Osteoporosis 2016: What are the properties of the perfect therapy?
Find out more at: https://nos.org.uk/conference
Exercise and Older People: A Community Practitioners PerspectiveUniversity of Bath
Presentation by Sarah Jarvis for ESRC Seminar Series on Ageing and Physical Activity -
"Physical Activity as a 'Career': A Life Course Perspective"
http://seminars.ecehh.org
Benefits of exercise are it affects on muscles,lungs,heart, brain, joints and bones. Exercise improves stamina and general health, and slows ageing effects
Learn more about the types, symptoms and causes of balance disorders. Diagnostic and treatment options such as vestibular rehabilitation and cognitive behavioral therapy will be discussed.
Understanding the Physical Impacts of Ageing: A Course for CarersIHNA Australia
This presentation is about understanding how ageing affects people and their everyday lives. This slideshow covers:
1. Strategies carers can use to promote healthy lifestyle practices.
2. Common problems carers may face with ageing clients.
3. Physical changes associated with ageing.
4. The impact changes associated with ageing may have on a person's everyday activities.
5. How to communicate potential risks and risks associated with ageing to the older person.
"The Science of Aging" by Martin Borch Jensen Impact.Tech
Slides from the inaugural Impact.tech seminar about the science of aging, healthspan and longevity. The presentation addresses questions such as: What is aging? Is aging treatable? What are the major biological processes that make up aging? What are the major breakthroughs in anti-aging science? How you can get involved in anti-aging as an entrepreneur or investor?
Impact.tech Launch Seminars are meant to give entrepreneurs and investors a launch into a topic where they can apply their skills to make a major positive impact for humanity and the world.
El 17 de octubre de 2014, la Fundación Ramón Areces celebró una nueva conferencia del ciclo 'Envejecimiento, Sociedad y Salud: envejecimiento y enfermedad', que organiza en colaboración con el Centro de Estudios del Envejecimiento. En esta ocasión, el doctor Valentín Fuster, director del Centro Nacional de Investigaciones Cardiovasculares Carlos III- CNIC, habló sobre 'Enfermedad subclínica de corazón y cerebro: el reto de la década'. En esta entrevista previa a su intervención, deja claro que nunca es tarde para cuidarse y que la clave no está tanto en el corazón, sino en el cerebro, donde se toman las decisiones para llevar hábitos de vida saludables.
Telomere Diagnostics in the areas of Stem Cells and Male Infertility | Life L...Life Length
Through Life Length’s new series of webinars we want to take Telomere Analysis Technology to clearly defined fields, in order to explore the benefits that telomere measurement can add to your practice.
In this third edition, we will look into the role that telomere analysis plays in the areas of Stem Cells and Male Infertility.
OSTEOPOROSIS:A Barebone guide to diagnosis and managementGovindRankawat1
“Progressive systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk”
True Definition: bone with lower density and higher fracture risk
WHO: utilizes Bone Mineral Density as definition (T score <-2.5)
Osteoporosis is silent because there are no symptoms initially.
The most common are fractures of the spine, hip, and wrist.
Osteoporosis is not an inevitable part of aging, but is a disease that can be prevented and treated, provided it is detected early.
The main goal of treating osteoporosis is to prevent such fractures in the first place.
Bare bone term used for “necked bone with necked eye”
“There is clearly a problem of underdiagnosis and undertreatment of osteoporosis and we want to raise awareness about the risk factors for osteoporosis so that those who need treatment get treatment”.
Learning Objectives
Utilize recent recommendations for osteoporosis prevention and treatment and how to apply them in practice.
Explain controversies surrounding pharmacologic osteoporosis therapy including side effects and the risk/benefit ratio of therapy.
Determine when and how to utilize the current pharmacologic therapies including anabolic versus anti-resorptive approaches and how to transition or discontinue treatment
Osteoporosis only causes symptoms when it is far advanced.
Symptoms include loss of height, deformed spine (“dowager’s hump”), unexplained back pain, and fractures.
It is best to detect problems at an early stage, when treatment is most effective.
The best test for detecting osteoporosis is bone densitometry, done with a technique called “Dual-energy X-ray Absorptiometry” or DXA.
Talent Identification in the Young PerformerCarl Page
Analysed and interpreted the key issues associated with the challenges and benefits of sport participation by aged participants. Reviewed and understood the mechanisms that explain life-span motor development and impairment and consider their value in the design and delivery of sport and physical activity participation opportunities. Also I adopted a critical approach to the evaluation of knowledge in the area of life-span motor development and impairment by interrogating its methodological and conceptual robustness. Finally I applied my knowledge from life-span motor development and impairment to sport and practitioner contexts.
Mike Trenell presents @ Alzheimer's Research UK Meeting Newcastlemtrenell
Prof Mike Trenell presents on the benefits of a physically active lifestyle on ageing and brain health at the 2014 Alzheimer's Research UK meeting in Newcastle, UK.
Physical Activity, Exercise and Type 2 Diabetes Preventionmtrenell
Dr Trenell talks about the roles of physical activity and exercise in the prevention of Type 2 diabetes.
The talk addresses some of the practical aspects of helping people to move more and sit less and how this could be used effectively in clinical care.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
7. Random Molecular Damage
Accumulation of Cellular Defects
Age-related frailty, disability and disease
DNA damage (genome instability)
Somatic mutations (copying errors,
imperfect repair)
Telomere shortening
Chromosome rearrangements
Mitochondrial-DNA mutations
Gene disruption by viruses, transposons etc
Aberrant epigenetic modifications
RNA damage
Transcription errors
Aberrant splicing
Protein damage
Misfolding
Synthesis errors
Aberrant post-translational modifications
Aberrant aggregation
Impaired protein turnover (catabolism)
Membrane damage
Oxidation
Kirkwood TBL. Nature 451, 664-667 (2008)
8. Life
Accumulation of lifestyle changes
Age-related frailty, disability and disease
Cardio respiratory
fitness
Cognitive function
Physical Activity
Diet
Muscle Mass Injuries
Sleep
Socioeconomic status
Weather
Exercise
Ageing
Strength
Disease
10. Combined impact of four health behaviours on survival
Epic Norfolk; free living healthy men and women 45-79
Healthy Ageing: Lifestyle Factors?
Khaw et al. PLoS Med 2008
• Smoking
• Fruit & Veg
• Alcohol
• Physical Activit
11. The challenge
Adapted from: Barabási AL.
N Engl J Med. 2007 26;357(4):404-7.
Chronological Age
Metabolic
Deregulation
Mitochondrial
changes?
Muscular
dystrophyNAFLD
T2 Diabetes
Exercise
Intolerance
CVD
12. Summary
We are living longer
Longevity varies
Lifestyle plays a key
role
17. 0.25
0.5
0.75
1
Quintiles of maximal exercise capacity
1 2 3 4 5
Relativeriskofdeath
Adjusted for age, sex, exam year, smoking status,
ECG response, baseline health conditions
As red but also % body fat
<8.7
>18.4
8.7–11.2
11.3–13.6
13.7–18.3
Sui X, et al. JAMA 298: 2507-2516 (2007)
Cardiovascular fitness and mortality: over 60yrs
2603 adults aged 60 years or older
19. Jackson, et al. Arch Intern Med 169, 1781–1787 (2009)
Women
Cardiofitness
(maxMETs)
BMI 20; PAI 3
BMI 20; PAI 0
5
10
15
8030 40 50 60 70 9020
Men
Cardiofitness
(maxMETs)
5
10
15
BMI 30; PAI 3
BMI 30; PAI 0
Age years
38. Summary
Mike Trenell www.MoveLab.org
8030 40 50 60 70 9020
Men
Cardiofitness
(maxMETs)
5
10
15
Age years
60
80
100
lProbability(%)SurvivalProbability(%)
0
20
40
60
80
FIT
UNFIT
>75yrs FIT
>75yrs UNFIT
<75yrs FIT
<75yrs UNFIT
39. FINISHED FILES ARE THE RE
SULT OF YEARS OF SCIENTI
FIC STUDY COMBINED WITH
THE EXPERIENCE OF YEARS...
40. Summary
Mike Trenell www.MoveLab.org
8030 40 50 60 70 9020
Men
Cardiofitness
(maxMETs)
5
10
15
Age years
60
80
100
lProbability(%)SurvivalProbability(%)
0
20
40
60
80
FIT
UNFIT
>75yrs FIT
>75yrs UNFIT
<75yrs FIT
<75yrs UNFIT
Editor's Notes
Describe what driver and conductor do.Pass through last two panels quickly. Reiterate – this is not exercise – this is everyday life (what you are doing now).
Data in white in maximal METS achieved during a progressive exercise test
Research has demonstrated that physical activity and cardiorespiratory fitness levels are low following stroke. Indeed I demonstrated in a cross sectional longitudinal study conducted as part of my PhD that total energy expenditure, physical activity and step counts are significantly reduced in the week following stroke and although levels were found to increase by three months post stroke by six months they had plateaued before reaching levels comparable to healthy controls and conducive to health. So how much physical activity are individuals undertaking at present following stroke? This is a study we carried out recently investigating energy expenditure and PA in 31 individuals following stroke in the North East. At baseline participants were expending less than 1840 calories per day almost 400 calories less than an age sex and BMI matched control group and were only taking just over 3000 steps per day in comparison to 8000 in healthy controls. PA plateau’d at 3 and six months step count only half that of governemtn recommendation 10,000 steps per day and MET level just above resting metabolic rate. Average length of stay 2 days for those who were on ward for whole 7 day monitoring period average under 1000 steps per day MET level basic metabolic rate1) To define energy expenditure and physical activity levels at baseline in individuals following stroke in comparison to an age, sex and BMI matched control group. 2) To establish whether physical activity and energy expenditure levels change over time following stroke.Inclusion; diagnosis stroke within 2 weeks, >50 yrs, mild/mod gait deficit, exclusion severe cognitive/speech probs mobility probs other than stroke, medical history.n=31 average age 73, BMI 27, NIHSS 2 (range 0-7), MRS (0-3) Barthel (60-100)Healthy 2200 vs. baseline 1840 baseline, 3 months 2100, 6 months 2093 nearly 400 calories less PA equivalent to 2 mars barsPAEE 79, baseline 28, 63 3 months, 66 6 monthsDaily steps healthy 7996, baseline 3111, 3 months 5763, 6 months 5927MET 1.3, baseline, 1.0 3 months 1.15, 6 months 1.16.
I went on to see if increasing energy expenditure and physical activity via a structured community based exercise programme would primarily improve metabolic risk factors associated with stroke risk such as dyslipidaemia and hypertension and secondarily what effect exercise would have on brain physiology, physical function, cognition and well being. The results of my randomised trial indicated that structured exercise is well tolerated with minimal risks and leads to improvements in self report of overall stroke recovery, cognition, cardiorespiratory fitness and walking speed and endurance. We also for the first time demonstrated using state of the art MRI techniques that exercise may be a way to reduce stroke and age related atrophy in the hippocampus.
I went on to see if increasing energy expenditure and physical activity via a structured community based exercise programme would primarily improve metabolic risk factors associated with stroke risk such as dyslipidaemia and hypertension and secondarily what effect exercise would have on brain physiology, physical function, cognition and well being. The results of my randomised trial indicated that structured exercise is well tolerated with minimal risks and leads to improvements in self report of overall stroke recovery, cognition, cardiorespiratory fitness and walking speed and endurance. We also for the first time demonstrated using state of the art MRI techniques that exercise may be a way to reduce stroke and age related atrophy in the hippocampus.
Data in white in maximal METS achieved during a progressive exercise test
There are 111,000 first strokes in the UK every year and stroke is the leading cause of disability in the UK and most countries worldwide. Unfortunately stroke is not an isolated event and if you have had one stroke your chances of having another are 30-40%. Due to the high incidence of stroke and the need for long term rehabilitation and nursing care stroke care has been estimated to cost the UK up to 2.5 billion per year and these costs are liekly to rise with an exepcted increase in stroke related burden in the next two decades. As most patients with stroke survive the initial illness the greatest health effect is usually the long term consequences for patients and their families. Despite the fact stroke is such a big problem there is a lack of high quality evidence on the most effective forms of stroke rehabilitation and in particular there is a lack of clear guidance on lifestyle interventions post stroke and their possible health benefits.